Table 1 From Phase I Targeted Systemic Exposure Study Of Paclitaxel In
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I targeted systemic exposure study of paclitaxel in ...
Table 1 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 1 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 3 from Phase I and Pharmacokinetic Study of Sequential Paclitaxel ...
Table 1 from Targeted Oral Delivery of Paclitaxel Using Colostrum ...
(PDF) Phase I study of sapanisertib with carboplatin and paclitaxel in ...
Table 1 from Targeted Oral Delivery of Paclitaxel Using Colostrum ...
(PDF) A phase I study of TAK-659 and paclitaxel in patients with taxane ...
Advertisement Space (300x250)
Table 1 from A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib ...
Table 1 from Phase II study of the combination of cetuximab and weekly ...
Table 1 from Mortality Not Correlated With Paclitaxel Exposure An ...
Table 1 from Randomized phase III study comparing paclitaxel/cisplatin ...
Table 1 from Prospective Study Testing a Simplified Paclitaxel ...
(PDF) Phase I and Pharmacokinetic Study of Sequential Paclitaxel and ...
(PDF) Phase I and Pharmacological Study of Paclitaxel Given Over 3 h ...
Phase I pharmacokinetic study of a weekly liposomal paclitaxel ...
Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion ...
Effect of oral drug dose on the systemic exposure to paclitaxel in ...
Advertisement Space (336x280)
Figure 1 from A First-Time-In-Human Phase I Clinical Trial of ...
Figure 1 from A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib ...
(PDF) Phase I trial and pharmacological study of a 3-hour paclitaxel ...
Phase I results of a phase I/II study of weekly nab-paclitaxel in ...
(PDF) A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein ...
Figure 1 from Study protocol of a phase II clinical trial evaluating ...
Table 1 from Short and Long-Term Effects of the Exposure of Breast ...
Table I. | Phase II Study of Weekly Paclitaxel as a Second-line ...
Figure 1. | Phase I Study of Combination Chemotherapy Consisting of ...
Preclinical Development and Phase I Study of ZSYY001, a Polymeric ...
Advertisement Space (336x280)
An open-label, phase IB/II study of abemaciclib with paclitaxel for ...
Figure 1 from The Safety and Efficacy of Weekly Paclitaxel ...
A randomized phase 2 study of sapanisertib in combination with ...
Selected phase II/III studies of weekly single-agent paclitaxel in ...
Table 1 from Survival Analysis and Clinical Outcomes between Paclitaxel ...
(PDF) Phase I/II Clinical Study of Pulsed Paclitaxel Radiosensitization ...